Exp Mol Med.
1998 Dec;30(4):186-191.
Enhancement of aflatoxin B1-induced enzyme altered hepatic foci in rats by treatment with carbon tetrachloride
- Affiliations
-
- 1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Abstract
- The effect of carbon tetrachloride (CCl4) on aflatoxin B1 (AFB1)-induced enzyme
altered hepatic foci has been examined in young male Fischer rats given AIN-76A
diet. A single i.p. dose of AFB1 (0.2 mg/kg body wt) was given to rats 24 h
after partial hepatectomy. Two weeks later, CCl4 (0.8 ml/kg body wt) was
injected i.p. once a week for 9 weeks. Animals were sacrificed 24 h after the
last dose of CCl4 and glutathione S-transferase placental form (GST-P) and
gamma-glutamyl transpeptidase (GGT) positive hepatic foci were analyzed by
immunohistochemical and histochemical methods, respectively. Ten weeks after
AFB1 dosing, treatment with CCl4 increased the number of AFB1-induced enzyme
altered foci several fold and produced a ten to twenty-fold increase in area and
volume. GST-P was more sensitive than GGT in detecting AFB1-induced enzyme
altered foci. Treatment with AFB1 or CCl4 produced mild hepatic fibrosis in
zones 1 and 3 respectively, whereas both treatments produced severe fibrosis in
zones 1 to 3 areas. Treatment with CCl4 after AFB1 dosing lowered hepatic GSH
levels by 20% and increased lipid peroxidation by 40%. It appears that CCl4, by
being an effective enhancer of AFB1-induced enzyme altered hepatic foci in the
rat, may mimic cirrhosis observed in human hepatocellular carcinoma.